Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial
出版年份 2018 全文链接
标题
Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial
作者
关键词
Pioglitazone, Type 2 diabetes mellitus, Adiponectin, Cardiac function, Percutaneous coronary intervention
出版物
HEART AND VESSELS
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-02-27
DOI
10.1007/s00380-018-1143-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis
- (2016) Nuo Li et al. BMC Cardiovascular Disorders
- Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis
- (2016) Dina M. Khodeer et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Insulin Resistance as a Predictor of the Late Catch-up Phenomenon After Drug-Eluting Stent Implantation
- (2016) Takaaki Komatsu et al. CIRCULATION JOURNAL
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis
- (2016) Shi-jie Zhao et al. PLoS One
- Pioglitazone for Secondary Stroke Prevention
- (2016) Meng Lee et al. STROKE
- Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways
- (2016) Tetsuya Kubota et al. Scientific Reports
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Pioglitazone Increases Circulating MicroRNA-24 With Decrease in Coronary Neointimal Hyperplasia in Type 2 Diabetic Patients – Optical Coherence Tomography Analysis –
- (2015) Soon Jun Hong et al. CIRCULATION JOURNAL
- Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up
- (2015) Liang-Ping Zhao et al. CORONARY ARTERY DISEASE
- Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
- (2015) H Yokoyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus
- (2014) Kyung Woo Park et al. JACC-Cardiovascular Interventions
- Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study
- (2013) Chien-Jung Lu et al. CEREBROVASCULAR DISEASES
- Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
- (2013) Salvatore Cassese et al. HEART
- Pioglitazone Decreases Coronary Artery Inflammation in Impaired Glucose Tolerance and Diabetes Mellitus
- (2013) Yoshikazu Nitta et al. JACC-Cardiovascular Imaging
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pioglitazone ameliorates systolic and diastolic cardiac dysfunction in rat model of angiotensin II-induced hypertension
- (2012) Aiko Sakamoto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of Insulin Resistance on Post-Procedural Myocardial Injury and Clinical Outcomes in Patients Who Underwent Elective Coronary Interventions With Drug-Eluting Stents
- (2012) Tadayuki Uetani et al. JACC-Cardiovascular Interventions
- Comparison of Three-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Among Insulin-Treated Diabetic, Non–Insulin-Treated Diabetic, and Non-Diabetic Patients from j-Cypher Registry
- (2011) Tomohisa Tada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner
- (2011) Yochai Birnbaum et al. BASIC RESEARCH IN CARDIOLOGY
- Role of Pioglitazone in the Prevention of Restenosis and Need for Revascularization After Bare-Metal Stent Implantation
- (2011) Dhavalkumar Patel et al. JACC-Cardiovascular Interventions
- Pioglitazone Reduces Atherogenic Outcomes in Type 2 Diabetic Patients
- (2011) Masahiko Igarashi et al. Journal of Atherosclerosis and Thrombosis
- Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes
- (2011) Akihiro Kudoh et al. LIFE SCIENCES
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Cellular and Molecular Changes Associated With Inhibitory Effect of Pioglitazone on Neointimal Growth in Patients With Type 2 Diabetes After Zotarolimus-Eluting Stent Implantation
- (2010) Soon Jun Hong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages
- (2009) Paska A. Permana et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
- (2009) D. K. Coletta et al. DIABETOLOGIA
- A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes
- (2009) Tsutomu Takagi et al. JACC-Cardiovascular Interventions
- Improved cardiac function after sirolimus-eluting stent placement in diabetic patients by pioglitazone: Combination therapy with statin
- (2009) Takuya Ozawa et al. Journal of Cardiology
- Effect of pioglitazone on left ventricular diastolic function and fibrosis of type III collagen in type 2 diabetic patients
- (2009) Gen Terui et al. Journal of Cardiology
- Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: A randomized prospective study using intravascular ultrasound
- (2008) Takashi Nakayama et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pioglitazone acutely stimulates adiponectin secretion from mouse and human adipocytes via activation of the phosphatidylinositol 3′-kinase
- (2008) Rocio I. Pereira et al. LIFE SCIENCES
- Thiazolidinediones: effects on insulin resistance and the cardiovascular system
- (2007) C E Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now